Why is Transgene Biotek falling/rising?

As of 04-Sep, Transgene Biotek Ltd's stock price is currently at 4.01, reflecting an increase of 0.16 or 4.16%. The stock has shown a positive performance today, outperforming its sector by 3.29% and has experienced consecutive gains over the last two days, resulting in a total return of 7.22% during this period. Despite this recent uptick, the stock has had a challenging performance over the longer term, with a year-to-date decline of 41.29% and a one-year drop of 50.98%. The stock's delivery volume has also increased, indicating rising investor participation, although there is no specific positive or negative dashboard data available to further clarify the factors influencing this movement.
Broader market context shows that while Transgene Biotek's stock has gained in the short term, it has underperformed compared to the Sensex, which has risen by 0.80% over the past week. The stock's recent gains contrast sharply with its longer-term performance, where it has consistently lagged behind the benchmark, particularly over the past month and year. This divergence suggests that while there may be short-term optimism reflected in today's price movement, the overall trend remains concerning when viewed against broader market performance.